1
Clinical Trials associated with VG-290131A Randomized, Double-Blind, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Orally Administered VG290131 in Healthy Adult Subjects
This is a randomized, double-blind, placebo-controlled phase I study to evaluate the safety, tolerability and PK profiles of orally administered VG290131 in healthy subjects. The main questions it aims to answer are:
The safety and tolerability of VG290131 when administered orally as a single dose and multiple doses in healthy subjects.
The pharmacokinetic (PK) profiles of VG290131 and the food effect on the PK profiles of VG290131 in healthy subjects.
Approximately 86 subjects will be enrolled in the study.
100 Clinical Results associated with VG-290131
100 Translational Medicine associated with VG-290131
100 Patents (Medical) associated with VG-290131
100 Deals associated with VG-290131